Evidence map›Paper›PMID 18707229›Full record

ArticleTissue engineering. Part A2008

Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam.

Leon J Nesti, Wan-Ju Li, Rabie M Shanti, Yi Jen Jiang, Wesley Jackson, Brett A Freedman, Timothy R Kuklo, Jeffrey R Giuliani, Rocky S Tuan

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03692221 (Percutaneous Image Guided Delivery of Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Symptomatic Degenerated Intervertebral Disc Disease), which is not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03692221 early_phase1withdrawnnot on this mapstarted 2019, after this paper: background citation

Percutaneous Image Guided Delivery of Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Symptomatic Degenerated Intervertebral Disc Disease

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2019 to 2022Enrolled0ConditionsDisc DegenerationArmsMSC Treatment group 1 (low dose), MSC Treatment group 2 (high dose), Healthy Control (no treatment)
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Advances and Prospects in Biomaterials for Intervertebral Disk Regeneration.Frontiers in bioengineering and biotechnology · 2021
    Review
  11. Article
  12. Advanced Strategies for the Regeneration of Lumbar Disc Annulus Fibrosus.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Intervertebral Disc Nucleus Repair: Hype or Hope?International journal of molecular sciences · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Leon J NestiCartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Wan-Ju Li
Rabie M Shanti
Yi Jen Jiang
Wesley Jackson
Brett A Freedman
Timothy R Kuklo
Jeffrey R Giuliani
Rocky S Tuan
National Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institutes of Health · USHoward Hughes Medical Institute · US

Funding

Cell and Molecular Biology of Skeletal DevelopmentZ01AR041131 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI TUAN, ROCKY S · 2002 to 2008
$6.0M
Novel Approaches in Tissue Engineering and Regenerative MedicineZIAAR041178 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI TUAN, ROCKY S · 2009 to 2009
$1.2M
Intramural NIH HHS Z01 AR041131
6 · The paper itself

Abstract

Degeneration of the intervertebral disc (IVD) represents a significant musculoskeletal disease burden. Although spinal fusion has some efficacy in pain management, spine biomechanics is ultimately compromised. In addition, there is inherent limitation of hardware-based IVD replacement prostheses, which underscores the importance of biological approaches to disc repair. In this study, we have seeded multipotent, adult human mesenchymal stem cells (MSCs) into a novel biomaterial amalgam to develop a biphasic construct that consisted of electrospun, biodegradable nanofibrous scaffold (NFS) enveloping a hyaluronic acid (HA) hydrogel center. The seeded MSCs were induced to undergo chondrogenesis in vitro in the presence of transforming growth factor-beta for up to 28 days. The cartilaginous hyaluronic acid-nanofibrous scaffold (HANFS) construct architecturally resembled a native IVD, with an outer annulus fibrosus-like region and inner nucleus pulposus-like region. Histological and biochemical analyses, immunohistochemistry, and gene expression profiling revealed the time-dependent development of chondrocytic phenotype of the seeded cells. The cells also maintain the microarchitecture of a native IVD. Taken together, these findings suggest the prototypic potential of MSC-seeded HANFS constructs for the tissue engineering of biological replacements of degenerated IVD.

Indexed as

Biocompatible MaterialsGene ExpressionHumansHyaluronic AcidIntervertebral DiscMesenchymal Stem CellsMicroscopy, Electron, ScanningNanotechnologyReverse Transcriptase Polymerase Chain ReactionTissue EngineeringTissue ScaffoldsBiocompatible MaterialsHyaluronic Acid

Identifiers

PMID18707229
PMCPMC2676103
OpenAlexW1980688341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.